(PRWeb.com) — A new Canadian study, published in March 2012 in the British Journal of Clinical Pharmacology, revealed that pregnant women who take selective serotonin reuptake inhibitors (SSRIs) antidepressants during or after pregnancy face an increased risk for developing high blood pressure. Paxil users faced more than an 80% risk for developing hypertension. Paxil (paroxetine), produced by GlaxoSmithKline and approved in 1992 by the FDA, is an SSRI prescribed to treat depression. In July 2010, Bloomberg News reported that a $2.4 billion set aside by GlaxoSmithKline to settle outstanding liabilities included the settlement of Paxil birth defect lawsuits brought by parents who said that use of Paxil during pregnancy caused persistent pulmonary hypertension in newborns (PPHN) or other problems for their babies. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Paxil severe adverse events.
The media spotlight is often a double-edged sword. No one knows this better than women and babies who suffer from Paxil severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.
In March 2012, a Canadian study was published in the British Journal of Clinical Pharmacology revealing that pregnant women who take selective serotonin reuptake inhibitors (SSRIs) antidepressants during or after pregnancy face an increased risk for developing high blood pressure. Users of any form of antidepressant during pregnancy were found to be 50% more likely to suffer high blood pressure while those taking SSRIs were 60% more likely; Paxil users faced more than an 80% risk for developing hypertension. Paxil (paroxetine), produced by GlaxoSmithKline and approved in 1992 by the FDA, is a selective serotonin reuptake inhibitor (SSRI) prescribed to treat depression. In July 2010, GlaxoSmithKline announced that it was setting aside $2.36 billion to cover the costs of outstanding liabilities including the settlement of Paxil Lawsuit cases brought by parents who said that use of Paxil during pregnancy caused persistent pulmonary hypertension in newborns (PPHN) or other problems for their babies.
Loading ...
Loading ...